Abstract:Carbon nanodots based on L-arginine (L-Arg) were developed for enhanced nitric oxide (NO) gas therapy for cancer. The L-Arg-based carbon nanodots (Arg-dots) produced high levels of NO in the tumor environment rich in endogenous H2O2. In vitro cell experiments revealed that the Arg-dots could kill tumor cells (including human breast cancer cell line MCF-7, female gastric cancer cell line BGC-823, male lung cancer cell line A549, and female leukemic cell line K562) but did not affect the activity of normal cells (human normal lung epithelial cell line BEAS-2B). The Arg-dots produced twice the amount of NO for an equivalent amount of L-Arg. Theoretical calculations showed that the carbonization structure of the Arg-dots promoted significantly more electrons toward the guanidinium groups of L-Arg and boosted the adsorption of H2O2 molecules. In vitro and in vivo investigations confirmed that the Arg-dots reduced the multidrug resistance (MDR) effect of the tumor cells (MCF-7/ADR cells) and produced a combined antitumor efficacy with traditional chemotherapeutic drugs (adriamycin [ADR]). The fluorescence property (quantum yield, 6.88%) allows the Arg-dots to be used as a suitable fluorescent probe for fluorescence imaging of tumor cells. The ultra-small size of the Arg-dots (diameter: ca. 2.5 nm) enables them not only to penetrate deep tumors and provide enhanced antitumor activity but also to be removed through kidney filtration and have a renal clearance property. STATEMENT OF SIGNIFICANCE: Nitric oxide (NO), which serves as a biological messenger, can be used in gas therapy for cancer. The development of a safe and efficient NO cancer therapy is, however, challenging because of the low NO release amount and poor tumor specificity of most NO donors. Many efforts have been made to overcome these drawbacks, but solving both these limitations through a single approach has been seldom achieved. In the present work, carbon nanodots (Arg-dots) from L-arginine were used for gas therapy of cancer. The Arg-dots produced NO in the H2O2-rich tumor environment. Theoretical calculations were consistent with the mechanism of enhanced NO release amount. The Arg-dots also reduced the multidrug resistance effect in cancer chemotherapy. In vivo and in vitro toxicity assessments confirmed that the Arg-dots have excellent biosafety.

Simultaneous Light-Triggered Release of Nitric Oxide and Carbon Monoxide from a Lipid-Coated Upconversion Nanosystem Inhibits Colon Tumor Growth

A Near-Infrared Triggered Multi-Functional Indocyanine Green Nanocomposite with NO Gas Release Function Inducing Improved Photothermal Therapy

MOF‐Coated Upconversion Nanoparticle Agents Enable Synergistic Photodynamic Therapy and Immunotherapy

Stimuli Responsive Nitric Oxide-Based Nanomedicine for Synergistic Therapy

Low dose soft X-ray-controlled deep-tissue long-lasting NO release of persistent luminescence nanoplatform for gas-sensitized anticancer therapy

H2O2-triggered controllable carbon monoxide delivery for photothermally augmented gas therapy

A multifunctional nanocomposite coated with a BSA membrane for cascaded nitric oxide therapy

Dual-Mode Reactive Oxygen Species-Stimulated Carbon Monoxide Release for Synergistic Photodynamic and Gas Tumor Therapy

Near‐infrared Light‐responsive Nitric Oxide Microcarrier for Multimodal Tumor Therapy (3/2023)

Multifunctional Carbon Monoxide Prodrug-Loaded Nanoplatforms for Effective Photoacoustic Imaging-Guided Photothermal/Gas Synergistic Therapy

Nitric oxide-based multi-synergistic nanomedicine: an emerging therapeutic for anticancer

A pH/Ultrasound dual-response biomimetic nanoplatform for nitric oxide gas-sonodynamic combined therapy and repeated ultrasound for relieving hypoxia

NIR-triggered Release of Caged Nitric Oxide Using Upconverting Nanostructured Materials.

Polyprodrug Nanomedicine for Chemiexcitation-Triggered Self-Augmented Cancer Chemotherapy and Gas Therapy

NIR-Triggered On-Demand Nitric Oxide Release for Enhanced Synergistic Phototherapy of Hypoxic Tumor

RSS and ROS Sequentially Activated Carbon Monoxide Release for Boosting NIR Imaging‐Guided On‐Demand Photodynamic Therapy

Upconversion: NIR‐Triggered Release of Caged Nitric Oxide using Upconverting Nanostructured Materials (Small 24/2012)

Endogenous NO-releasing Carbon Nanodots for Tumor-specific Gas Therapy

In situ-activated photothermal nanoplatform for on-demand NO gas delivery and enhanced colorectal cancer treatment

L-Arginine self-delivery supramolecular nanodrug for NO gas therapy

X-ray-Triggered CO Release Based on GdW 10 /MnBr(CO) 5 Nanomicelles for Synergistic Radiotherapy and Gas Therapy